abnormal lung vasculature morphology_Gucy1a3<tm1.1Brou>/Gucy1a3<tm1.1Brou>

http://metadb.riken.jp/0004007I129S1Sv129X1SvJGucy1a3tm11BrouGucy1a3tm11BrouGucy1a3tm11Brou

abnormal lung vasculature morphology_Gucy1a3<tm1.1Brou>/Gucy1a3<tm1.1Brou>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• guanylate cyclase 1, soluble, alpha 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:1926562

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Gucy1a3<tm1.1Brou>/Gucy1a3<tm1.1Brou>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Gucy1a3<tm1.1Brou>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal lung vasculature morphology
  http://purl.obolibrary.org/obo/MP_0004007

文献

http://purl.org/net/cito/citesAsAuthority

• Pieter. Vermeersch, et.al., Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia., Circulation, 2007, 116
  http://rdf.ncbi.nlm.nih.gov/pubmed/17679618